SCHEMBL19211537

SCHEMBL19211537

c1ccc(CNCCN(Cc2ccccc2)Cc2ccccn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.58
MAPT P10636 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
LIN28A Q9H9Z2 1/20 0.58
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
CHRM2 P08172 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515742 0.88 CHRM2 (0.55) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL825189 0.86 SMN1; SMN2 (0.68) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL4404505 0.86 CHRM2 (0.53) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL23481363 0.85 MAPT (0.54) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL5562538 0.85 SMN1; SMN2 (0.81) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL28241166 0.84 MEN1 (0.61) TDP1MAPTHDAC3HDAC1HDAC2
SCHEMBL4409089 0.84 CHRM2 (0.57) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL14293611 0.81 CHRM2 (0.48) TDP1MAPTSMN1; SMN2LIN28ACHRM2
SCHEMBL5590271 0.81 MAPT (0.68) TDP1MAPTSMN1; SMN2LIN28ACYP1A2
SCHEMBL29670844 0.81 MAPT (0.68) TDP1MAPTSMN1; SMN2LIN28ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118955363-A Ligand recovery method based on water-soluble copper complex 常熟理工学院 2024-11-15 CN disclosed
US-11904307-B2 Organometallic complexes of sequential tetradentate monoanionic ligands and uses thereof in ring opening polymerization of cyclic esters RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2024-02-20 US disclosed
EP-3414275-B1 ORGANOMETALLIC COMPLEXES OF SEQUENTIAL TETRADENTATE MONOANIONIC LIGANDS AND USES THEREOF IN RING OPENING POLYMERIZATION OF CYCLIC ESTERS UNIV RAMOT (IL) 2023-07-05 EP disclosed
US-20220395820-A1 ORGANOMETALLIC COMPLEXES OF SEQUENTIAL TETRADENTATE MONOANIONIC LIGANDS AND USES THEREOF IN RING OPENING POLYMERIZATION OF CYCLIC ESTERS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2022-12-15 US disclosed
US-11452998-B2 Organometallic complexes of sequential tetradentate monoanionic ligands and uses thereof in ring opening polymerization of cyclic esters RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2022-09-27 US disclosed
US-20190039058-A1 ORGANOMETALLIC COMPLEXES OF SEQUENTIAL TETRADENTATE MONOANIONIC LIGANDS AND USES THEREOF IN RING OPENING POLYMERIZATION OF CYCLIC ESTERS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2019-02-07 US disclosed
EP-3414275-A1 ORGANOMETALLIC COMPLEXES OF SEQUENTIAL TETRADENTATE MONOANIONIC LIGANDS AND USES THEREOF IN RING OPENING POLYMERIZATION OF CYCLIC ESTERS Ramot at Tel-Aviv University Ltd. (IL) 2018-12-19 EP disclosed
WO-2017137990-A1 ORGANOMETALLIC COMPLEXES OF SEQUENTIAL TETRADENTATE MONOANIONIC LIGANDS AND USES THEREOF IN RING OPENING POLYMERIZATION OF CYCLIC ESTERS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395820-A1 ORGANOMETALLIC COMPLEXES OF SEQUENTIAL TETRADENTATE MONOANIONIC LIGANDS AND USES THEREOF IN RING OPENING POLYMERIZATION OF CYCLIC ESTERS NCLN, NCL, LGMN TDP1 3794/4885MAPT 3240/4885SMN1; SMN2 3967/4885
US-11904307-B2 Organometallic complexes of sequential tetradentate monoanionic ligands and uses thereof in ring opening polymerization of cyclic esters NCLN, NCL, LGMN TDP1 3794/4885MAPT 3240/4885SMN1; SMN2 3967/4885
US-11452998-B2 Organometallic complexes of sequential tetradentate monoanionic ligands and uses thereof in ring opening polymerization of cyclic esters NCLN, NCL, LGMN TDP1 3794/4885MAPT 3240/4885SMN1; SMN2 3967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.